Stay updated on Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 instead of Revision: v3.6.4, indicating a backend/template update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-08-11T16:49:32.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.6.3 to v3.6.4, representing a small site update.
    Difference
    0.0%
    Check dated 2026-07-28T12:21:53.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing Revision: v3.6.0, indicating a recent platform update. This reflects an underlying version change rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-30T01:13:31.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    New navigation/help sections have been added to the page, including How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment label. The site revision badge has been updated to Revision: v3.6.0, with the older Revision: v3.5.5 removed.
    Difference
    0.5%
    Check dated 2026-06-15T20:07:01.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5 indicating an updated version, and no trial details or results are affected.
    Difference
    0.1%
    Check dated 2026-06-08T17:09:22.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page shows a new revision number (v3.5.4) replacing the previous v3.5.3, indicating a minor internal update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-18T05:54:33.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.